Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) will report its next earnings on Dec 12 – Dec 16 (Est.). The company reported the earnings of $-0.32/Share in the last quarter where the estimated EPS by analysts was $-0.37/share. The difference between the expected and actual EPS was $0.05/share, which represents an Earnings surprise of 13.5%.

Many analysts are providing their Estimated Earnings analysis for Arrowhead Pharmaceuticals, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.32/share. These analysts have also projected a Low Estimate of $-0.37/share and a High Estimate of $-0.31/share.

Some buy side analysts are also providing their Analysis on Arrowhead Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 3 analysts have given a Buy signal, 2 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 6 Analysts reported that the Price Target for Arrowhead Pharmaceuticals, Inc. might touch $15 high while the Average Price Target and Low price Target is $10.33 and $5 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Arrowhead Pharmaceuticals, Inc. got Downgrade on 30-Nov-16 where investment firm William Blair Downgrade the stock from Outperform to Mkt Perform.

Arrowhead Pharmaceuticals, Inc. closed its last trading session at $4.39 with the loss of -67.2%. The Market Capitalization of the company stands at 87.49 Million. The Company has 52-week high of $8.22 and 52-week low of $1.42. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -70.34% where SMA50 and SMA200 are -76.23% and -75% respectively. The Company Touched its 52-Week High on Aug 24, 2016 and 52-Week Low on Feb 11, 2016.

The Relative Volume of the company is 17.79 and Average Volume (3 months) is 1.02 million. Arrowhead Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -79.5%. The Return on Equity (ROE) value stands at -99.8%. While it’s Return on Investment (ROI) value is -86.5%.

While looking at the Stock’s Performance, Arrowhead Pharmaceuticals, Inc. currently shows a Weekly Performance of -67.57%, where Monthly Performance is -75.17%, Quarterly performance is -79.22%, 6 Months performance is -76.7% and yearly performance percentage is -76.59%. Year to Date performance value (YTD perf) value is -76.59%. The Stock currently has a Weekly Volatility of 9.90% and Monthly Volatility of 8.52%.